Citadel Advisors
CLPT icon

Citadel Advisors’s ClearPoint Neuro CLPT Stock Holding History

Citadel Advisors’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$806K Buy
45,200
+3,200
+8% +$40K ﹤0.01% 8741
2026
Q1 		$382K Sell
42,000
-36,200
-46% -$457K ﹤0.01% 9912
2025
Q4 		$1.07M Sell
78,200
-5,600
-7% -$104K ﹤0.01% 7247
2025
Q3 		$1.83M Buy
83,800
+47,800
+133% +$563K ﹤0.01% 6256
2025
Q2 		$430K Buy
36,000
+5,900
+20% +$74.3K ﹤0.01% 8983
2025
Q1 		$358K Buy
30,100
+13,000
+76% +$202K ﹤0.01% 9198
2024
Q4 		$263K Sell
17,100
-9,000
-34% -$117K ﹤0.01% 9924
2024
Q3 		$293K Buy
26,100
+22,700
+668% +$217K ﹤0.01% 9388
2024
Q2 		$18.3K Sell
3,400
-1,800
-35% -$10.4K ﹤0.01% 12718
2024
Q1 		$35.4K Buy
5,200
+3,100
+148% +$21.7K ﹤0.01% 12517
2023
Q4 		$14.3K Sell
2,100
-2,400
-53% -$13.6K ﹤0.01% 12886
2023
Q3 		$22.5K Sell
4,500
-12,800
-74% -$76.2K ﹤0.01% 12532
2023
Q2 		$125K Sell
17,300
-14,100
-45% -$120K ﹤0.01% 10586
2023
Q1 		$265K Sell
31,400
-6,700
-18% -$58.7K ﹤0.01% 9632
2022
Q4 		$323K Sell
38,100
-97,400
-72% -$923K ﹤0.01% 9154
2022
Q3 		$1.4M Buy
135,500
+120,400
+797% +$1.59M ﹤0.01% 6286
2022
Q2 		$197K Sell
15,100
-2,100
-12% -$21.5K ﹤0.01% 10710
2022
Q1 		$179K Sell
17,200
-34,400
-67% -$313K ﹤0.01% 11655
2021
Q4 		$579K Sell
51,600
-9,500
-16% -$142K ﹤0.01% 9339
2021
Q3 		$1.08M Buy
61,100
+4,100
+7% +$76.9K ﹤0.01% 7937
2021
Q2 		$1.09M Buy
+57,000
New +$1.1M ﹤0.01% 8153

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM

Citadel Advisors's CLPT Position: Q2 2026 in Review

Citadel Advisors opened a new position in ClearPoint Neuro (CLPT) in Q2 2026: 48,688 shares worth $869K. The stake represents ﹤0.01% of the portfolio and ranks #8560 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in CLPT as recently as Q4 2025.

Citadel Advisors first reported a position in CLPT in Q3 2019 and has held it in 20 quarters since. The position peaked at $1.88M in Q3 2025. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Citadel Advisors held 48,688 shares of ClearPoint Neuro worth $869K as of Q2 2026.
  • ClearPoint Neuro was a new Citadel Advisors position in Q2 2026.
  • ClearPoint Neuro made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #8560 holding.
  • Citadel Advisors first reported a position in ClearPoint Neuro in Q3 2019 and has held it in 20 quarters since.
  • Citadel Advisors's ClearPoint Neuro position peaked at $1.88M in Q3 2025.
  • 129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.